Month: March 2026
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007
Written by Customer Service on . Posted in Public Companies.
Abaxx Announces Fourth Quarter and Year-End 2025 Earnings and Business Update Call
Written by Customer Service on . Posted in Public Companies.
RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger
Written by Customer Service on . Posted in Public Companies.
SPIE announces the winners of Innovation Day 2026
Written by Customer Service on . Posted in Public Companies.
Cielo Provides Update on Proposed Acquisition and Announces Investor Summit Presentation
Written by Customer Service on . Posted in Mergers And Acquisitions.
Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Verde AgriTech Announces Q4 & FY 2025 Earnings Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
